Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
51 studies found for:    " June 02, 2010":" July 02, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" June 02, 2010":" July 02, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodology for Rapid Scale up of Painless and Bloodless National Circumcision Programs, in Urban and Remote Rural Settings
Conditions: Male Circumcision;   HIV Prevention;   HIV Infections
Intervention: Device: The PrePex a novel device for adult male circumcision
2 Recruiting Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
Condition: HIV Infection
Interventions: Behavioral: Linkage-to-Care Component: Financial Incentive (FI);   Behavioral: Linkage-to-Care Component: Standard of Care (SOC);   Behavioral: Viral Suppression Component: FI;   Behavioral: Viral Suppression Component: SOC;   Behavioral: Prevention for Positives Component: Counseling and SOC;   Behavioral: Prevention for Positives Component: SOC
3 Active, not recruiting HIV/AIDS, Severe Mental Illness and Homelessness
Conditions: HIV;   AIDS
Intervention: Behavioral: Skills Building - Motivational Interviewing
4 Completed Epidermal Nerve Fiber Density, Fat and Mitochondrial Parameters in Thai HIV+ Patients on d4T and HIV- Patients
Condition: HIV
Intervention:
5 Completed
Has Results
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
Conditions: HIV Seroconversion;   Stimulant Abuse
Intervention: Drug: Truvada
6 Completed Safety and Pharmacokinetic Trial in Healthy HIV-Negative Women to Assess the Delivery of Dapivirine From a Vaginal Ring
Condition: HIV Infections
Interventions: Drug: dapivirine;   Drug: placebo
7 Unknown  Comparative Effectiveness of Web-based Versus Traditional Adolescent HIV Prevention
Conditions: HIV Infections;   Hepatitis;   Sexually Transmitted Infections
Interventions: Behavioral: Traditional Prevention;   Behavioral: Web-based Prevention
8 Completed Pharmacokinetics of Low Dose Raltegravir
Condition: HIV Infections
Intervention: Drug: raltegravir
9 Completed HIV Testing in Non-traditional Settings Study
Condition: HIV
Interventions: Other: Questionnaire;   Other: Focus Group Discussion;   Other: HIV test (serum or salivary);   Other: Semi-structured telephone interview
10 Active, not recruiting Autologous Transplant in HIV Patients (BMT CTN 0803)
Conditions: Lymphoma;   HIV
Intervention: Procedure: Autologous transplant
11 Completed The Influence of Ritonavir, Alone and in Combination With Lopinavir, on Fenofibric Acid Pharmacokinetics in Healthy Volunteers
Conditions: HIV;   Fenofibrate;   Protease Inhibitors;   Hypertriglyceridemia;   Glucuronosyltransferase
Interventions: Drug: Fenofibrate;   Drug: Ritonavir;   Drug: Lopinavir/Ritonavir
12 Completed
Has Results
HIV Rapid Testing & Counseling in Sexually Transmitted Disease (STD) Clinics in the U.S.
Conditions: HIV/AIDS;   Sexually Transmitted Infections
Intervention: Behavioral: RESPECT-2 Counseling
13 Completed The Effects of Spirulina Platensis on Insulin Resistance in HIV-infected Patients
Conditions: Insulin Resistance;   HIV/AIDS
Interventions: Dietary Supplement: Spirulina platensis;   Dietary Supplement: Soya bean
14 Unknown  Tenofovir Renal Toxicity and Glomerular Filtration Rate (GFR) Validation
Conditions: Renal Function;   HIV Infection
Intervention: Other: Tc99mDTPA renal clearance
15 Completed Protective Efficacy Against Tuberculosis (TB) Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)
Conditions: Tuberculosis;   HIV Infections
Interventions: Biological: MVA85A/AERAS-485;   Biological: Candida albicans Skin Test Antigen
16 Completed
Has Results
Clinical Study of TUTI-16 in HIV-1 Infected and Uninfected Subjects
Condition: HIV Infections
Interventions: Biological: TUTI-16 (0.2mg);   Biological: TUTI-16 (1.0 mg)
17 Unknown  Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz
Condition: HIV Infections
Intervention: Drug: generic FDC of TDF/3TC/EFV
18 Completed Metabolic and Psychological Changes Associated With Menopause Among Women With HIV
Conditions: HIV Infections;   Menopause
Intervention:
19 Unknown  Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy
Conditions: HIV Infections;   Tuberculosis
Intervention: Drug: LPV/r
20 Completed A Drug Interaction Study Between Simvastatin, Atorvastatin, Rosuvastatin, and GSK2248761 in Healthy Subjects.
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK2248761;   Drug: Simvastatin;   Drug: Atorvastatin;   Drug: Rosuvastatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years